FDA approves irinotecan liposome for first-line treatment of metastatic pancreatic adenocarcinoma

Trial

NAPOLI 3

Drugs

Onivyde (irinotecan liposome) · Topoisomerase I inhibitor, oxaliplatin · Platinum agent

Condition

Gastrointestinal